BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6126714)

  • 1. Detection of adrenoleucodystrophy carriers by means of evoked potentials.
    Moloney JB; Masterson JG
    Lancet; 1982 Oct; 2(8303):852-3. PubMed ID: 6126714
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA probes and carriers of X-linked disease.
    Wood S
    Lancet; 1982 Nov; 2(8309):1219-20. PubMed ID: 6128523
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenoleukodystrophy: manifestations of a protean disorder: report of a recently identified kindred.
    Chancellor AM; Glasgow GL; Lambie NK; Synek BJ
    N Z Med J; 1989 May; 102(867):220-2. PubMed ID: 2717104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenoleukodystrophy: heterogeneity in two brothers.
    Elrington GM; Bateman DE; Jeffrey MJ; Lawton NF
    J Neurol Neurosurg Psychiatry; 1989 Mar; 52(3):310-3. PubMed ID: 2538572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage of adrenoleukodystrophy to a polymorphic DNA probe.
    Aubourg PR; Sack GH; Meyers DA; Lease JJ; Moser HW
    Ann Neurol; 1987 Apr; 21(4):349-52. PubMed ID: 2883927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adrenoleukodystrophy in the child and adrenomyeloneuropathy. Study of 2 families].
    Mabin D; Borsotti JP; Bercovici JP; Aubourg P; Kerlan V; Le Fur JM; Le Mevel JC
    Neurophysiol Clin; 1989 Aug; 19(4):311-25. PubMed ID: 2796927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Familial adrenoleukodystrophy].
    Le Fur JM; Le Meur F; Parent P; Toudic L; Castel Y
    J Genet Hum; 1985 Dec; 33(5):427-34. PubMed ID: 4093772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new therapeutic approach for X-linked adrenoleukodystrophy.
    Cappa M; Bertini E; Di Capua M; Rimoldi M; Uziel G
    Eur J Pediatr; 1990 May; 149(8):595-6. PubMed ID: 2347360
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
    Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
    Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier detection for adrenoleukodystrophy by high-performance liquid chromatography.
    Sakai T; Antoku Y; Tsukamoto K; Imanishi K; Iwashita H; Gotoh I
    Exp Neurol; 1988 Jun; 100(3):556-62. PubMed ID: 3366206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenoleucodystrophy: a review of nine cases.
    Monaghan H; Tempany E; McMenamin J; O'Donohoe N
    Ir Med J; 1987 May; 80(5):142-4. PubMed ID: 3597036
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenoleukodystrophy and variants. Clinical, neurophysiological and biochemical studies in patients and family members.
    Goto I; Kobayashi T; Antoku Y; Tobimatsu S; Kuroiwa Y
    J Neurol Sci; 1986 Jan; 72(1):103-12. PubMed ID: 3081689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Spastic paraparesis and adrenal gland insufficiency: adrenomyeloneuropathy].
    Zijlmans JM; van Marion WF
    Ned Tijdschr Geneeskd; 1987 Jan; 131(5):208-11. PubMed ID: 3822010
    [No Abstract]   [Full Text] [Related]  

  • 14. [Apropos of a familial case of adrenoleukodystrophy related to X chromosome diagnosed prenatally].
    Parent P; Le Meur F; Alix D; Le Fur JM; Toudic L; Castel Y
    Pediatrie; 1987; 42(4):297-301. PubMed ID: 3671029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial spinocerebellar degeneration as an expression of adrenoleukodystrophy.
    Kobayashi T; Noda S; Umezaki H; Goto I; Suzuki S; Kitaguchi T; Kuroiwa Y
    J Neurol Neurosurg Psychiatry; 1986 Dec; 49(12):1438-40. PubMed ID: 3468205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evoked response studies in patients with adrenoleukodystrophy and heterozygous relatives.
    Garg BP; Markand ON; DeMyer WE; Warren C
    Arch Neurol; 1983 Jun; 40(6):356-9. PubMed ID: 6847442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenoleukodystrophy.
    O'Neill BP; Moser HW
    Can J Neurol Sci; 1982 Nov; 9(4):449-52. PubMed ID: 6758925
    [No Abstract]   [Full Text] [Related]  

  • 18. First trimester prenatal diagnosis of adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis to a DNA probe.
    Boué J; Oberle I; Heilig R; Mandel JL; Moser A; Moser H; Larsen JW; Dumez Y; Boué A
    Hum Genet; 1985; 69(3):272-4. PubMed ID: 3856557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier detection in X-linked adrenoleukodystrophy by determination of very long chain fatty acid levels and by linkage analysis.
    Notarangelo LD; Parolini O; Baiguini G; Buzi F; Paterlini C; Perini A; Rimoldi M; Tiberti S; Uziel G; Notarangelo L
    Eur J Pediatr; 1992 Oct; 151(10):761-3. PubMed ID: 1425799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenoleukodystrophy carrier state presenting as a chronic nonprogressive spinal cord disorder.
    Noetzel MJ; Landau WM; Moser HW
    Arch Neurol; 1987 May; 44(5):566-7. PubMed ID: 3579671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.